R2* mapping and reduced field‐of‐view diffusion‐weighted imaging for preoperative assessment of nonenlarged lymph node metastasis in rectal cancer

Jing Wang,Shan Hu,Ping Liang,Xuemei Hu,Yaqi Shen,Yang Peng,Ihab Kamel,Zhen Li
DOI: https://doi.org/10.1002/nbm.5174
2024-05-09
NMR in Biomedicine
Abstract:A significant difference was noted between R2* and ADC for the prediction of NLNM status of rectal cancer. The diagnostic performance of R2* was significantly greater than ADC in the assessment of NLNM status. R2* was a compelling factor of nonenlarged lymph node metastasis in rectal cancer. The aim of the current study is to investigate the diagnostic value of R2* mapping versus reduced field‐of‐view diffusion‐weighted imaging (rDWI) of the primary lesion of rectal cancer for preoperative prediction of nonenlarged lymph node metastasis (NLNM). Eighty‐one patients with pathologically confirmed rectal cancer underwent preoperative R2* mapping and rDWI sequences before total mesorectal excisions and accompanying regional lymph node dissections. Two radiologists independently performed whole‐tumor measurements of R2* and apparent diffusion coefficient (ADC) parameters on primary lesions of rectal cancer. Patients were divided into positive (NLNM+) and negative (NLNM‐) groups based on their pathological analysis. The tumor location, maximum diameter of the tumor, and maximum short diameter of the lymph node were assessed. R2* and ADC, pT stage, tumor grade, status of mesorectal fascia, and extramural vascular invasion were also studied for their potential relationships with NLNM using multivariate logistic regression analysis. The NLNM+ group had significantly higher R2* (43.56 ± 8.43 vs. 33.87 ± 9.57, p
radiology, nuclear medicine & medical imaging,biophysics,spectroscopy
What problem does this paper attempt to address?